Table 3.
Unit | N | LSMean | SEM | P value | |
---|---|---|---|---|---|
Villus height | 0.049 | ||||
BMDa | µm | 16 | 2018.6x | 49.5 | |
ABF | µm | 16 | 2162.8y | 49.5 | |
Crypt depth | 0.746 | ||||
BMD | µm | 16 | 384.8 | 15.3 | |
ABF | µm | 16 | 391.9 | 15.3 | |
Ratio | 0.339 | ||||
BMD | µm/µm | 16 | 5.6 | 0.2 | |
ABF | µm/µm | 16 | 6.0 | 0.2 | |
Muscularis thickness | 0.348 | ||||
BMD | µm | 16 | 193.6 | 8.7 | |
ABF | µm | 16 | 205.3 | 8.7 | |
Total thickness | 0.130 | ||||
BMD | µm | 16 | 2498.4 | 70.2 | |
ABF | µm | 16 | 2653.1 | 70.2 |
BMD broilers that received feed with 50 g/ton of bacitracin methylene disalicylate beginning at 31 days post hatch, ABF treatment group where broilers received no bacitracin methylene disalicylate; Ratio, villus height to crypt depth ratio; Total thickness, villus height + crypt depth + muscularis depth
aData were similar for day and the interaction of day and BMD treatment; therefore, data shown are for differences in BMD dietary treatment where data from day 3 and 7 are combined
xyzchanges in superscript within row indicate differences between pairwise comparisons after Tukey’s post hoc adjustment (P < 0.05)